We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Prime Minister Rishi Sunak makes a speech on how we have a global responsibility to understand and address the risks surrounding AI, in order to realise all its benefits and opportunities for future generations.
As the world grapples with the challenges and opportunities presented by the rapid advancement of Artificial Intelligence, the UK will host the first major global summit on AI safety.
Chapters 6 and 7.
Two leading experts appointed to spearhead preparations for UK to host AI Safety Summit as £13 million unveiled to revolutionise healthcare research.
Regulatory Horizons Council publishes today 2 independent reports on the regulation of neurotechnology and artificial intelligence (AI) as a medical device.
FOI 1406 We received a request under the Freedom of Information Act 2000 (FOIA) for information about a primate experiment published in the…
Scientists will use the International Space Station to carry out experiments seeking to improve understanding of currently incurable child brain tumours and the muscle ageing process, thanks to UK Space Agency funding.
Speech by Sir James Bevan, Chief Executive, Environment Agency, UCL Institute for Sustainable Resources.
The Prime Minister addressed the Lord Mayor's Banquet.
School Standards Minister Nick Gibb addresses Buckingham University PGCE students.
The MHRA is reviewing the evidence relating to the very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) associated with medicines containing pseudoephedrine
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).